Literature DB >> 3338232

A controlled trial of methylphenidate in black adolescents. Attentional, behavioral, and physiological effects.

R T Brown1, S B Sexson.   

Abstract

The short-term effects of methylphenidate were examined on behavioral, laboratory, academic, and physiological measures in 11 black male adolescents diagnosed as having attention deficit disorder (ADD). In a double-blind, crossover design with randomized order, the subjects received placebo and each of three methylphenidate doses (0.15 mg/kg, 0.30 mg/kg, and 0.50 mg/kg) for a period of 2 weeks per medication dosage. Significant drug effects were found for the majority of measures. In general, the higher doses resulted in the most beneficial response in behavioral, academic, and laboratory measures of attention and impulsivity. However, a significant linear increase occurred in diastolic blood pressure. The results suggest that methylphenidate is an effective adjunct to the treatment of ADD in adolescents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338232     DOI: 10.1177/000992288802700204

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  7 in total

Review 1.  Attention deficit hyperactivity disorder in African American children: what can be concluded from the past ten years?

Authors:  Torri W Miller; Joel T Nigg; Robin L Miller
Journal:  Clin Psychol Rev       Date:  2008-10-11

Review 2.  Evidence-based psychosocial treatments for ethnic minority youth.

Authors:  Stanley J Huey; Antonio J Polo
Journal:  J Clin Child Adolesc Psychol       Date:  2008-01

3.  Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.

Authors:  H Lynn Starr; Jason Kemner
Journal:  J Natl Med Assoc       Date:  2005-10       Impact factor: 1.798

4.  Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.

Authors:  Els F van den Ban; Patrick C Souverein; Herman van Engeland; Hanna Swaab; Toine C G Egberts; Eibert R Heerdink
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-28       Impact factor: 4.328

5.  Methylphenidate and hospitalized adolescents with conduct disorder: Dose effects on classroom behavior, academic performance, and impulsivity.

Authors:  R T Brown; S L Jaffe; J Silverstein; H Magee
Journal:  J Youth Adolesc       Date:  1991-10

6.  Methylphenidate off-label use and safety.

Authors:  Thierry Trenque; Emmanuelle Herlem; Malak Abou Taam; Moustapha Drame
Journal:  Springerplus       Date:  2014-06-07

Review 7.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.